Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant

There is a growing interest in using monoclonal antibodies (mAbs) in the early stages of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection to prevent disease progression. Little is known about the efficacy of mAbs against the delta variant of concern and its clinical presentatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicchitto, Gaetano, Cardillo, Lorena, de Martinis, Claudio, Sabatini, Paola, Marchitiello, Rosita, Abate, Giovanna, Rovetti, Adele, Cavallera, Antonietta, Apuzzo, Camillo, Ferrigno, Francesco, Fusco, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950724/
https://www.ncbi.nlm.nih.gov/pubmed/35337057
http://dx.doi.org/10.3390/v14030650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950724/
https://www.ncbi.nlm.nih.gov/pubmed/35337057
http://dx.doi.org/10.3390/v14030650

Ejemplares similares